[{"HighlightedText":"<b>as one of a limited number of selected european life science companies</b>","Value":"as one of a limited number of selected european life science companies"},{"HighlightedText":"<b>atmp</b>","Value":"atmp"},{"HighlightedText":"<b>bio international convention 2026</b>","Value":"bio international convention 2026"},{"HighlightedText":"<b>for personalised cancer immunotherapy</b>","Value":"for personalised cancer immunotherapy"},{"HighlightedText":"<b>accelerator</b>","Value":"accelerator"},{"HighlightedText":"<b>and cellerys</b>","Value":"and cellerys"},{"HighlightedText":"<b>and its ongoing research into autoimmune diseases such as ms</b>","Value":"and its ongoing research into autoimmune diseases such as ms"},{"HighlightedText":"<b>and multiple sclerosis</b>","Value":"and multiple sclerosis"},{"HighlightedText":"<b>g-rex grant</b>","Value":"g-rex grant"},{"HighlightedText":"<b>g-rex grant to advance personalised cancer immunotherapy</b>","Value":"g-rex grant to advance personalised cancer immunotherapy"},{"HighlightedText":"<b>hanjing xie as its new chief medical officer</b>","Value":"hanjing xie as its new chief medical officer"},{"HighlightedText":"<b>hanjing xio chief medical officer neogap therapeutics</b>","Value":"hanjing xio chief medical officer neogap therapeutics"},{"HighlightedText":"<b>hans grönlund-neogap therapeutics-stina l wickström-ki</b>","Value":"hans grönlund-neogap therapeutics-stina l wickström-ki"},{"HighlightedText":"<b>immnuotherapy</b>","Value":"immnuotherapy"},{"HighlightedText":"<b>immuno-oncology</b>","Value":"immuno-oncology"},{"HighlightedText":"<b>immunology</b>","Value":"immunology"},{"HighlightedText":"<b>in partnership with ey</b>","Value":"in partnership with ey"},{"HighlightedText":"<b>in the study</b>","Value":"in the study"},{"HighlightedText":"<b>including a tailored market entry project worth sek 250</b>","Value":"including a tailored market entry project worth sek 250"},{"HighlightedText":"<b>common virus that most people acquire early in life</b>","Value":"common virus that most people acquire early in life"},{"HighlightedText":"<b>contract research organization</b>","Value":"contract research organization"},{"HighlightedText":"<b>biotech</b>","Value":"biotech"},{"HighlightedText":"<b>biotech company focused on developing personalised cancer immunotherapy</b>","Value":"biotech company focused on developing personalised cancer immunotherapy"},{"HighlightedText":"<b>biotech company specialising in personalised immunotherapy</b>","Value":"biotech company specialising in personalised immunotherapy"}]